Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer

Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer

The intermediate-risk category of papillary thyroid cancer (PTC) comprises heterogeneous patients within a wide range of stages and varied care management. Understanding the risk features of recurrence observed after the initial therapy should be emphasized. We aimed to evaluate the prognostic signi...

Full description

Bibliographic Details
Main Authors:	Xi Jia, Yuanbo Wang, Lulu Yang, Kun Fan, Runyi Tao, Hui Liu, Xiaobao Yao, Aimin Yang, Guangjian Zhang, Rui Gao
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Diagnostics
Subjects:	radionuclide imaging persistent recurrence intermediate risk papillary thyroid cancer
Online Access:	https://www.mdpi.com/2075-4418/12/5/1254

Similar Items

Laser Ablation Treatment of Recurrent Lymph Node Metastases from Papillary Thyroid Carcinoma
by: Chiara Offi, et al.
Published: (2021-11-01)

Synchronous mixed medullary‐papillary carcinoma and papillary multifocal carcinoma of the thyroid with cervical lymph node metastases
by: Raquel Lalanda, et al.
Published: (2023-06-01)

Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
by: Bin Wang, et al.
Published: (2023-04-01)

Mixed medullary—papillary thyroid carcinoma with mixed lymph node metastases: A case report
by: Vanessa Guerreiro, et al.
Published: (2021-05-01)

Analysis of tumor recurrence factors of the patients with intermediate risk papillary thyroid carcinoma after radioactive iodine treatment
by: TANG Linglin, LI Li, LAI Yi, LIU Jianjun, ZHOU Xiang
Published: (2023-11-01)

Papillary Thyroid Carcinoma: Analysis of the Central Compartmentʼs Lymph Nodes Metastases
by: Ján Sojak, et al.
Published: (2017-06-01)

Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications
by: Rui Gao, et al.
Published: (2019-02-01)

TERT RNAscope analysis of sub-centimetric papillary thyroid carcinomas and synchronous lymph node metastases
by: Marie-Lisa Eich, et al.
Published: (2024-04-01)

Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.
by: Chang-Hee Lee, et al.
Published: (2018-01-01)

Multifocality is associated with central neck lymph node metastases in papillary thyroid microcarcinoma
by: Zheng W, et al.
Published: (2018-06-01)

Warthin-like variant of papillary thyroid carcinoma with lymph node metastases: a case report and review of the literature
by: Andrii Hryshchyshyn, et al.
Published: (2024-01-01)

Clinical Value of 131I in Diagnosis and Treatment of Recurrent Papillary Thyroid Carcinoma
by: JING Zhengjun, et al.
Published: (2022-06-01)

Protocols for Dual Tracer PET/SPECT Preclinical Imaging
by: Julia E. Blower, et al.
Published: (2020-05-01)

Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
by: Young Woo Chang, et al.
Published: (2016-10-01)

Cervical lymph node metastasis prediction of postoperative papillary thyroid carcinoma before 131I therapy based on clinical and ultrasound characteristics
by: Fei Yu, et al.
Published: (2023-02-01)

Simultaneous Metastases of Papillary Thyroid Carcinoma and Neuroendocrine Tumor of the Cecum to Cervical Lymph Nodes: A Case Report
by: Matija Romić, et al.
Published: (2023-01-01)

Analysis of Risk Factors for Lymph Node Metastases in Elderly Patients with Papillary Thyroid Micro-Carcinoma
by: Fu GM, et al.
Published: (2020-08-01)

131I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy
by: Sun N, et al.
Published: (2019-06-01)

A Clinical Predictive Model of Central Lymph Node Metastases in Papillary Thyroid Carcinoma
by: Zipeng Wang, et al.
Published: (2022-06-01)

Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients
by: Cui Zhang, et al.
Published: (2022-04-01)

The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma
by: Rafael Selbach Scheffel, et al.
Published: (2020-08-01)

Diagnostic value of xSPECT/CT-based tomographic fusion imaging for bone metastases in children
by: Wang Na, Kan Ying, Wang Wei, Yang Jigang
Published: (2022-08-01)

Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma
by: Teng Ma, et al.
Published: (2023-09-01)

Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size
by: Xiaojun Zhang, et al.
Published: (2021-07-01)

Radiofrequency Ablation for Cervical Metastatic Lymph Nodes in Children and Adolescents With Papillary Thyroid Carcinoma: A Preliminary Study
by: Lin Yan, et al.
Published: (2021-05-01)

Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect
by: Xue Li, et al.
Published: (2024-01-01)

Cystic lateral neck mass: Papillary thyroid carcinoma metastases with concomitant lymphangioma
by: Chitturi Ramya, et al.
Published: (2019-01-01)

Papillary thyroid microcarcinoma should not be used as the basis for postoperative 131I therapy
by: CAI Xiaoyu, ZHANG Ruiguo, HU Yujing, WANG Renfei, BIAN Yanzhu
Published: (2023-11-01)

Nomograms for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma: Stratification by size
by: Jia-Wei Feng, et al.
Published: (2022-09-01)

Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma
by: Xiao-Wan Bo, et al.
Published: (2020-10-01)

Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature
by: Adam Stenman, et al.
Published: (2022-02-01)

Efficacy and safety of percutaneous ultrasound-guided microwave ablation for cervical metastatic lymph nodes from papillary thyroid carcinoma
by: Zhi-Yu Han, et al.
Published: (2020-01-01)

A nomogram based on clinicopathological and ultrasound characteristics to predict central neck lymph node metastases in papillary thyroid cancer
by: Fei Chen, et al.
Published: (2024-02-01)

The effect of positive thyroglobulin antibodies on the prognosis and treatment response in patients with papillary thyroid carcinoma
by: Mojgan Sanjari, et al.
Published: (2024-02-01)

Clinical Effects of Microwave Ablation in the Treatment of Low-Risk Papillary Thyroid Microcarcinomas and Related Histopathological Changes
by: Chenya Lu, et al.
Published: (2021-09-01)

Ultrasonographic Features of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinomas and Macrocarcinomas
by: Young Gyung Shin, et al.
Published: (2015-02-01)

Efficacy and safety of microwave ablation for cervical metastatic lymph nodes arising post resection of papillary thyroid carcinoma: a retrospective study
by: Xiao-Jing Cao, et al.
Published: (2020-01-01)

Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients
by: Rong Wu, et al.
Published: (2020-01-01)

Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases
by: Yijie Huang, et al.
Published: (2021-03-01)

Impact of age on central lymph nodes involvement in papillary thyroid cancer
by: Shadi Awny, et al.
Published: (2024-04-01)